Optimized human clotting factor VIII gene expression cassettes and their use
View Patent ↗The invention relates to synthetic liver-specific promoters and expression constructs for producing polypeptides and functional nucleic acids in the liver of a subject. The invention further relates to Factor VIII proteins containing modifications in the amino acid sequence of the Factor VIII protein, as well as nucleic acid constructs encoding the Factor VIII proteins and methods of using these compositions to treat a bleeding disorder.
1. An isolated polynucleotide comprising a synthetic liver specific promoter, wherein the promoter comprises the nucleotide sequence as set forth in SEQ ID NO: 1.
2. The polynucleotide of claim 1 , wherein the promoter is operably linked to an intron.
3. The polynucleotide of claim 2 , wherein the intron is from heavy chain variable region (V H ) 4 (V H 4).
4. The polynucleotide of claim 3 , wherein the promoter and the intron together comprise the nucleotide sequence as set forth in SEQ ID NO: 2.
5. The polynucleotide of claim 1 , wherein the promoter is operably linked to a polynucleotide of interest.
6. The polynucleotide of claim 5 , wherein the polynucleotide of interest encodes a polypeptide or a functional nucleic acid.
7. The polynucleotide of claim 6 , wherein the polynucleotide of interest encodes Factor VIII.
8. A vector comprising the polynucleotide of claim 1 .
9. An isolated transformed cell comprising the polynucleotide of claim 1 .
10. The polynucleotide of claim 6 , wherein the polynucleotide of interest encodes a clotting factor.
11. The polynucleotide of claim 7 , wherein the polynucleotide interest encodes a B domain-deleted Factor VIII.
12. The polynucleotide of claim 11 , wherein the polynucleotide of interest comprises the nucleotide sequence as set forth in SEQ ID NO: 3.
13. The polynucleotide of claim 11 , wherein the promoter and the polynucleotide of interest comprises the nucleotide sequence as set forth in SEQ ID NO: 4.
14. The polynucleotide of claim 1 , further comprising a polyadenylation site downstream of the polynucleotide of interest.
15. The vector of claim 8 , wherein the vector is a viral vector.
16. The vector of claim 14 , wherein the vector is an adeno-associated virus vector.